Terapio
Terapio is a VC backed, government funded biopharmaceutical company developing the RLIP76 protein for biodefense and commercial applications
- Stage Product In Development
- Industry Biotechnology
- Location Austin, TX, USA
- Currency USD
- Founded January 2006
- Employees 11
- Website terapio.com
Company Summary
Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein. The lead application is a medical countermeasure for radiation exposure for civilian, military, first responder and astronaut/flight crew populations in addition to other defense and clinical indications. RLIP76 works though the oxidative stress pathway and is efficacious as both a prophylactic and mitigator by effluxing toxins from the cell.
Team
-
Curt Bilby, PhDPresident and CEO
-
Casey Cunningham, MDCo-founder and Chief Medical Officer
-
Henry HebelVP of Drug Development
-
Elizabeth Leffel, PhD, MPHVP Preclinical/Nonclinical Programs
Previous Investors
-
Santé VenturesUnconfirmedState of TexasUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.